Focus on the Use of Resveratrol in Bladder Cancer
Authors:
- Alessandro ZucchiAZAlessandro Zucchi
- Francesco ClapsFCFrancesco Claps
- Antonio Luigi PastoreAntonio Luigi Pastore
- Alessandro PerottiAPAlessandro Perotti
- Andrea BiaginiAndrea Biagini
- Luana SallicandroLuana Sallicandro
- Rosaria GentileRGRosaria Gentile
- Concetta CagliotiCCConcetta Caglioti
- Federico PalazzettiFPFederico Palazzetti
- Bernard FiorettiBFBernard Fioretti
Open Access
- 26 February 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (5) , 4562
Abstract
Bladder cancer is the most common tumor of the urinary system, with a high incidence in the male population. Surgery and intravesical instillations can eradicate it, although recurrences are very common, with possible progression. For this reason, adjuvant therapy should be considered in all patients. Resveratrol displays a biphasic dose response both in vitro and in vivo (intravesical application) with an antiproliferative effect at high concentrations and antiangiogenic action in vivo (intraperitoneal application) at a low concentration, suggesting a potential role for it in clinical management as an adjuvant to conventional therapy. In this review, we examine the standard therapeutical approach to bladder cancer and the preclinical studies that have investigated resveratrol in xenotransplantation models of bladder cancer. Molecular signals are also discussed, with a particular focus on the STAT3 pathway and angiogenic growth factor modulation.Keywords
Funding Information
- Fondo Integrativo Speciale per la Ricerca (FISR2020)
This publication has 104 references indexed in Scilit:
- SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial FunctionCell Metabolism, 2012
- Resveratrol given intraperitoneally does not inhibit the growth of high-risk t(4;11) acute lymphoblastic leukemia cells in a NOD/SCID mouse modelInternational Journal of Oncology, 2011
- Resveratrol Metabolites Do Not Elicit Early Pro-apoptotic Mechanisms in Neuroblastoma CellsJournal of Agricultural and Food Chemistry, 2011
- Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor AxisCancer Research, 2010
- An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder CancerEuropean Urology, 2009
- AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activityNature, 2009
- SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein KinaseJournal of Biological Chemistry, 2008
- Calorie Restriction Increases Muscle Mitochondrial Biogenesis in Healthy HumansPLOS Medicine, 2007
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006